The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Classification of molecular subtypes of high-grade serous ovarian cancer by MALDI-Imaging.
Wanja Nikolai Kassuhn
No Relationships to Disclose
Oliver Klein
No Relationships to Disclose
Silvia Darb-Esfahani
No Relationships to Disclose
Hedwig Lammert
No Relationships to Disclose
Sylwia Handzik
No Relationships to Disclose
Eliane T Taube
No Relationships to Disclose
Wolfgang D Schmitt
Honoraria - AstraZeneca
Research Funding - Myriad Genetics
Oliver Dorigo
Consulting or Advisory Role - Clovis Oncology; Eisai; Genentech; Merck; molecular health; PACT Pharma
Speakers' Bureau - AstraZeneca; Tesaro
Research Funding - AstraZeneca (Inst); Genentech (Inst); IMV (Inst); Millennium (Inst); PharmaMar (Inst)
Expert Testimony - Chihak & Martel
David Horst
No Relationships to Disclose
Carlotta Keunecke
No Relationships to Disclose
Felix Dreher
No Relationships to Disclose
Joshy George
No Relationships to Disclose
David Bowtell
Research Funding - AstraZeneca; BeiGene; Genentech/Roche
Michael Hummel
Consulting or Advisory Role - various
Travel, Accommodations, Expenses - various
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche Diagnostics; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
Nils Blüthgen
No Relationships to Disclose
Hagen Kulbe
No Relationships to Disclose
Elena Ioana Braicu
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche; Roche; Tesaro
Research Funding - AstraZeneca; Bayer; Roche